ASHP Recommends Greater Clarity and Consistency in FDA Communications on REMS
ASHP spoke at a hearing called by the FDA in an attempt to understand the impact of the use of REMS on the healthcare system and to identify improved approaches for minimizing their burden on patients and providers.
ASHP encouraged FDA officials to work toward a centralized electronic means for all REMS, including registration, provider education, and patient documentation requirements. Click here to view the statement submitted by ASHP.
# # #